HomeMarkets Markets Moderna Comes Swinging For Pfizer, GSK In Scorching RSV Battle By news January 18, 2023 0 145 FacebookTwitterPinterestWhatsApp Moderna (MRNA) stock surged early Wednesday after the company said its experimental RSV vaccine proved nearly 84% effective against respiratory …This post was originally published on this site Share FacebookTwitterPinterestWhatsApp Subscribe Login Notify of new follow-up comments new replies to my comments Please login to comment 0 Comments Inline Feedbacks View all comments Stay Connected156,664FansLike396,312FollowersFollow2,320SubscribersSubscribe Latest Articles Markets Tsingtao Tuesday – China Pours More Stimulus on the Markets Earth, Climate Global crises are multiplying: Here’s how science can help our public decision-makers News Meet the New Autocrats Who Dismantle Democracies from Within Markets U.S. officials say Russia is embracing AI for its election influence efforts Earth, Climate Can you trust companies that say their plastic products are recyclable? US regulators may crack down on deceptive claims Load more